UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
    Ayman El-Sheikh
  2. Study to Investigate Ulcerative Colitis
    Steven Polyak
  3. Study to Determine how Patients with Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer Respond to Treatment
    Mohammed Milhem
  4. Study to Establish Database that will Collect Clinical and Survey Data Outcomes of Head and Neck Squamous Cell Carcinoma
    Nitin Pagedar
  5. Trial for Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
    Ayman El-Sheikh
  6. Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome
    Ayman El-Sheikh
  7. Study of How Women Tolerate Chemotherapy
    David Bender
  8. Effectiveness pf Positron Emission Tomography (PET) Scan on Tumors
    M. Sue O'Dorisio
  9. EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
    Daniel Vaena
  10. A Pilot Study of Paclitaxel as Adjuvant Chemotherapy for Carcinoma of the Esophagus or GE Junction following Completion of Induction Chemoradiation and Surgical Resection
    Taher Abu Hejleh
  11. Anti-Cancer Activity of Alisertib in Patients with PTCL
    Brian Link
  12. Cell Transplant Study for Multiple Myeloma, POEMS, or Multiple Myeloma with Amyloidosis
    Guido Tricot
  13. Phase 1/2 Study Epigenetic Modification of BRAF-mutated Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine Combined with Vemurafenib
    Mohammed Milhem
  14. A Phase 1, open-label, multi-center, dose escalation study of the safety, tolerability, pharmacodynamic and pharmacokinetic properties of...
    John Buatti
  15. A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects…
    Sarah Holstein
  16. A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect of Vandetanib on Cellular Markers of Proliferation and Apoptosis in Invasive Breast Cancer
    Ronald Weigel
  17. Phase 1b, Open-label, Multicenter Study of Urelumab (BMS-663513) in Combination with Rituximab in Subjects with Relapsed/Refractory B-Cell Malignancies
    Brian Link
  18. A phase II randomized, multicenter study of treatment-free remission in chronic myeloid leukemia in chronic phase (CML-CP) patients who achieve and sustain MR4.5 after switching to nilotinib
    Thomas Carter
  19. A Phase III, Multicenter, Double-Blind, Randomized, Placebo- Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in…
    Eva Tsalikian
  20. A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children with Juvenile Myelomonocytic Leukemia (JMML)
    Ayman El-Sheikh

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.